Lab Reagents
Human IgG antibody Laboratories manufactures the s1 subunit of spike protein reagents distributed by Genprice. The S1 Subunit Of Spike Protein reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact Spike Protein. Other S1 products are available in stock. Specificity: S1 Category: Subunit Group: Of Spike
Of Spike information
Recombinant Coronavirus Spike Protein (MERS-CoV S1; 56-295) |
P1514-10 |
Biovision |
10µg |
EUR 187.2 |
Recombinant Coronavirus Spike Protein (MERS-CoV S1; 56-295) |
P1514-50 |
Biovision |
50µg |
EUR 661.2 |
Recombinant Coronavirus Spike Protein (SARS-CoV S1; His tag) |
P1516-10 |
Biovision |
10µg |
EUR 308.4 |
Recombinant SARS-CoV-2 Spike Protein S1 (His-tag) |
P1540-10 |
Biovision |
10 µg |
EUR 211.2 |
Recombinant SARS-CoV-2 Spike Protein S1 (His-tag) |
P1540-50 |
Biovision |
50 µg |
EUR 818.4 |
Recombinant SARS-CoV-2 Spike Protein S1 (Fc tag) |
P1541-10 |
Biovision |
10 µg |
EUR 211.2 |
Recombinant SARS-CoV-2 Spike Protein S1 (Fc tag) |
P1541-50 |
Biovision |
50 µg |
EUR 818.4 |
Recombinant (HEK) SARS Coronavirus Spike S1 protein (His-tag) |
SARSS15-R-10 |
Alpha Diagnostics |
10 ug |
EUR 416.4 |
SARS-CoV-2 (COVID-19) Spike S1 Antibody |
9083-002mg |
ProSci |
0.02 mg |
EUR 229.7 |
|
Description: Coronavirus disease 2019 (COVID-19), formerly known as 2019-nCoV acute respiratory disease, is an infectious disease caused by SARS-CoV-2, a virus closely related to the SARS virus (1). The disease is the cause of the 2019–20 coronavirus outbreak (2). The structure of 2019-nCoV consists of the following: a Spike protein (S), hemagglutinin-esterease dimer (HE), a membrane glycoprotein (M), an envelope protein (E) a nucleoclapid protein (N) and RNA. Coronavirus invades cells through Spike (S) glycoproteins, a class I fusion protein. It is the major viral surface protein that coronavirus uses to bind to the human cell surface receptor. It also mediates the fusion of host and viral cell membrane, allowing the virus to enter human cells and begin infection (3). The spike protein is the major target for neutralizing antibodies and vaccine development (4). The protein modeling suggests that there is strong interaction between Spike protein receptor-binding domain and its host receptor angiotensin-converting enzyme 2 (ACE2), which regulate both the cross-species and human-to-human transmissions of COVID-19 (5). The recent study has shown that the SARS-CoV-2 spike protein binds ACE2 with higher affinity than SARS-CoV spike protein (6). |
SARS-CoV-2 (COVID-19) Spike S1 Antibody |
9083-01mg |
ProSci |
0.1 mg |
EUR 594.26 |
|
Description: Coronavirus disease 2019 (COVID-19), formerly known as 2019-nCoV acute respiratory disease, is an infectious disease caused by SARS-CoV-2, a virus closely related to the SARS virus (1). The disease is the cause of the 2019–20 coronavirus outbreak (2). The structure of 2019-nCoV consists of the following: a Spike protein (S), hemagglutinin-esterease dimer (HE), a membrane glycoprotein (M), an envelope protein (E) a nucleoclapid protein (N) and RNA. Coronavirus invades cells through Spike (S) glycoproteins, a class I fusion protein. It is the major viral surface protein that coronavirus uses to bind to the human cell surface receptor. It also mediates the fusion of host and viral cell membrane, allowing the virus to enter human cells and begin infection (3). The spike protein is the major target for neutralizing antibodies and vaccine development (4). The protein modeling suggests that there is strong interaction between Spike protein receptor-binding domain and its host receptor angiotensin-converting enzyme 2 (ACE2), which regulate both the cross-species and human-to-human transmissions of COVID-19 (5). The recent study has shown that the SARS-CoV-2 spike protein binds ACE2 with higher affinity than SARS-CoV spike protein (6). |
Mouse Monoclonal Anti-Porcine epidemic diarrhea virus Spike protein S1 (PEDV-S1) IgM, unlabeled |
PEDV13-M |
Alpha Diagnostics |
100 ul |
EUR 578.4 |
SARS-CoV-2 (COVID-19) Biotinylated Spike S1 Recombinant Protein |
10-208 |
ProSci |
0.1 mg |
EUR 752.1 |
Description: The spike protein (S) of coronavirus (CoV) attaches the virus to its cellular receptor, angiotensinconverting enzyme 2 (ACE2). A defined receptor-binding domain (RBD) on S mediates this interaction.The S protein plays key parts in the induction of neutralizing-antibody and T-cell responses, as well as protective immunity. |
SARS-CoV-2 (COVID-19) Spike Glycoprotein-S1, Recombinant protein |
39-111 |
ProSci |
0.05 mg |
EUR 1520.7 |
Description: A human infecting coronavirus (viral pneumonia) called 2019 novel coronavirus, 2019-nCoV was found in the fish market at the city of Wuhan, Hubei province of China on December 2019. The 2019-nCoV shares an 87% identity to the 2 bat-derived severe acute respiratory syndrome 2018 SARS-CoV-2 located in Zhoushan of eastern China. 2019-nCoV has an analogous receptor-BD-structure to that of 2018 SARS-CoV, even though there is a.a. diversity so thus the 2019-nCoV might bind to ACE2 receptor protein (angiotensin-converting enzyme 2) in humans. While bats are possibly the host of 2019-nCoV, researchers suspect that animal from the ocean sold at the seafood market was an intermediate host. RSCU analysis proposes that the 2019-nCoV is a recombinant within the viral spike glycoprotein between the bat coronavirus and an unknown coronavirus. |
SARS-CoV-2 (COVID-19) Spike S1 Recombinant Protein (biotin) |
21-806 |
ProSci |
50 ug |
EUR 437.1 |
Description: SARS-CoV-2 shares 79.5% sequence identity with SARS-CoV and is 96.2% identical at the genome level to the bat coronavirus BatCoV RaTG133, suggesting it had originated in bats. The coronaviral genome encodes four major structural proteins: the Spike (S) protein, Nucleocapsid (N) protein, Membrane/Matrix (M) protein and the Envelope (E) protein. The SARS Envelope (E) protein contains a short palindromic transmembrane helical hairpin that seems to deform lipid bilayers, which may explain its role in viral budding and virion envelope morphogenesis. The SARS Membrane/Matrix (M) protein is one of the major structural viral proteins. It is an integral membrane protein involved in the budding of the viral particles and interacts with SARS Spike (S) protein and the Nucleocapsid (N) protein. The N protein contains two domains, both of them bind the virus RNA genome via different mechanisms.The CoV Spike (S) protein assembles as trimer and plays the most important role in viral attachment, fusion and entry. It is composed of a short intracellular tail, a transmembrane anchor and a large ectodomain that consists of a receptor binding S1 subunit (RBD domain) and a membrane-fusing S2 subunit. The S1 subunit contains a receptor binding domain (RBD), which binds to the cell surface receptor angiotensin-converting enzyme 2 (ACE2) present at the surface of epithelial cells.The SARS-CoV-2 Spike Protein S1 (RBD) (rec.) (His) is used as antigen in the Serological ELISA Kit to detect anti-SARS-CoV-2 Spike (RBD) antibodies in serum or plasma (see SARS-CoV-2 (Spike RBD) IgG Serological ELISA Kit; AG-45B-0020).This biotinylated version of SARS-CoV-2 Spike Protein S1 (RBD) (rec.) (His) forms a tetramer in the presence of streptavidin and this tetramer can be used to activate B cell memory to SARS-CoV-2 Spike protein. |
Human CellExp™ SARS-CoV-2 Spike Protein (S1), Recombinant |
P1531-10 |
Biovision |
10 µg |
EUR 235.2 |
Human CellExp™ SARS-CoV-2 Spike Protein (S1), Recombinant |
P1531-50 |
Biovision |
50 µg |
EUR 709.2 |
Human CellExp™ SARS-CoV-2 Spike Protein (S1), Recombinant |
P1555-10 |
Biovision |
10μg |
EUR 235.2 |